Outbreak of meningitis linked to University of Kent and the area of Canterbury

Between 13th and 16th March 2026, the UK Health Security Agency (UKHSA) identified 15 cases of invasive meningococcal disease in the South East. Four cases have been confirmed as meningococcal group B. Most cases are students from the University of Kent, Canterbury, and sixth-form students from local secondary schools. Several cases share exposure at a Canterbury nightclub (Club Chemistry) on 5–7 March.

The illness has been severe with rapid deterioration, and two deaths have occurred. This situation is evolving and advice may be updated as information emerges.

There are no changes to national guidance on the management of suspected meningococcal disease.

A letter was sent to all University of Kent students and staff with information to ensure rapid identification of symptomatic individuals. Antibiotic chemoprophylaxis is being offered to:

• all students who live on Canterbury campus
• all staff who live or work in affected halls of residence
• anyone who attended Club Chemistry on 5, 6 and 7 March
• close contacts who have been identified by UKHSA

Local Kent clinics are currently offering prophylaxis. However, if an individual has returned home and not already received prophylaxis through UKHSA coordinated clinics, they should be directed to their home GP surgery for a prescription (first line treatment is ciprofloxacin as a single dose).

 As part of the response UKHSA have asked GP surgeries to offer MenB vaccinations upon request to a small cohort of patients who cannot access the vaccination at local vaccination clinics at the University of Kent because they have returned home from campus.

Meningococcal sepsis should be considered in a rapidly deteriorating patient with sepsis even in the absence of a non-blanching rash, which is usually a late sign.

Meningitis: signs and symptoms leaflet and poster - GOV.UK